Informed Prostate Cancer Patient Support

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach | Prostate Cancer and Prostatic Diseases nature.com MyProstateScore in men considering repeat biopsy: validation of a simple testing approach Chinnaiyan, Arul M. 28–35 minutes Abstract Background Men with persistent risk of Grade Group (GG) ≥ 2 cancer after a negative biopsy present a unique clinical challenge. The validated MyProstateScore test is clinically-available for pre-biopsy risk stratification. In biopsy-naïve patients, we recently validated a straightforward testing approach to rule-out GG ≥ 2 cancer with 98% negative predictive value (NPV) and 97% sensitivity. In the current study, we established a practical MPS-based testing approach in men with a previous negative biopsy being considered for repeat biopsy. Methods Patients provided post-digital rectal examination urine pr

NHS expedites rollout of Bayer’s darolutamide for prostate cancer

Effective management of prostate cancer surgery through advanced technology | The Financial Express financialexpress.com Effective management of prostate cancer surgery through advanced technology guest 6–8 minutes The most effective form of treatment for prostate cancer is surgery; however, open surgery carries with it the potential for complication-based morbidity. By Dr. Abhay Kumar In India, prostate cancer is one of the most common types of cancer in men. Like the majority of other cancers, prostate cancer is difficult to diagnose in its early stages, as individuals don’t show any symptoms until the cancer has progressed to an advanced stage. The prevalence of prostate cancer is massive and is estimated to be the second most common type of cancer in India, especially among older men in metropolitan cities such as Kolkata, Bangalore, and Pune. Statistics have shown it to be one